Skip to main content
Hui-Ying Li on Muck Rack

Hui-Ying Li

As seen in: Nature, Wiley Online Library, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hui-Ying

Contact Hui-Ying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Chidamide‑augmented BEAM conditioning and maintenance in first-remission T‑cell lymphoma: a single‑arm phase 2 experience

|
By Si-yuan Chen, Rong-Ji Mu, Hui-Ying Li, Li Wang, Shu Cheng, Peng-Peng Xu, Zhong Zheng, Ming-Ci Cai, Yao-Hui Huang, Di Fu, Yu-Jia Huo, Wei Tang, Yi-Ge Shen, Lin-Di Zhao, Hui-Juan Zhong, Meng-Meng Ji
| Nature Verified
Introduction T‑cell lymphoma (TCL) is a rare subset of non‑Hodgkin lymphoma (NHL), accounting for 5–10% of cases in Western countries and 15–20% in Asia [1]. TCL encompasses multiple pathological subtypes, including nodal T‑follicular helper cell lymphoma, angioimmunoblastic‑type (nTFHL‑AI), peripheral T‑cell lymphoma‑not otherwise specified (PTCL‑NOS), and anaplastic large‑cell lymphoma (ALCL) [2]. First‑line CHOP‑based regimens yield unsatisfactory outcomes [2].
Open in Who Shared Issue with article?

Low-Dose Chidamide Maintenance Therapy After Hematopoietic Stem Cell Transplantation for T-Cell Acute Lymphoblastic Leukemia: A Case Series

|
By Hui-Ying Li, Shen-Hao Liu, Ai-Ni Deng
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data presented in this study are available in this article. Peer Review For transparency, the peer review documents associated with this article are available at https://doi.org/10.1002/hon.70225.
Open in Who Shared Issue with article?

Genetic and Transcriptomic Profiles Identify Potential Therapeutic Targets of Concurrent Follicular and Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma

|
By Rui Sun, Rui-Chi Li, Hui-Ying Li
| Wiley Online Library Verified
1 Introduction Concurrent presence of follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) components (FL/DLBCL) within a single lesion is classified as composite lymphoma [1]. Transformed follicular lymphoma (tFL) refers to the histological transformation of follicular lymphoma into an aggressive B-cell lymphoma, predominantly DLBCL, typically occurring from months to years after the initial diagnosis [2].
Open in Who Shared Issue with article?
See all 4 articles